See the DrugPatentWatch profile for Qbrelis
Qbrelis (brolucizumab) is a prescription eye‑injection used mainly for wet age‑related macular degeneration (AMD). Because it’s a specialty drug, the list price is higher than many conventional medicines. Below is a general snapshot of what patients in the United States may expect, plus some tips for navigating costs. Prices can vary by location, pharmacy, payer, and the specific dosing schedule, so always confirm with your provider and insurance company.
---
1. Rough Cost Estimates (U.S.)
| Category | Approximate Cost | Notes |
|----------|-----------------|-------|
| Manufacturer list price | $3,000–$3,500 per 0.05 mg vial | This is the “wholesale acquisition cost” (WAC) that pharmacies bill to insurance. |
| Patient‑share (coinsurance) | $300–$800 per injection | Depending on your health plan, you may be responsible for 20–40 % of the list price. |
| Out‑of‑pocket maximum | $5,000–$8,000 per year | Most commercial plans set an annual out‑of‑pocket limit; once you hit it, the plan pays 100 %. |
| Medicare | Copay range: $0–$75 per injection | Medicare Part B covers the drug; the exact copay depends on the plan (traditional vs. Advantage). |
| Clinical trials / manufacturer discount | $0–$500 | If you’re on a trial or qualify for the manufacturer’s discount program, the cost can be reduced dramatically. |
Key point: The list price is the amount the pharmacy charges your insurer. The out‑of‑pocket amount you pay is often much lower because of insurance coverage, copays, or discount programs.
---
2. How the Cost is Determined
1. Wholesale Acquisition Cost (WAC) – the price the manufacturer charges the pharmacy.
2. Insurance Contractual Discounts – negotiated reductions between the insurer and pharmacy.
3. Copay/Coinsurance – percentage or flat fee you pay after insurance.
4. Manufacturer Discount Programs – “patient assistance” programs that can lower the price for uninsured or under‑insured patients.
5. Clinical Trial Participation – many patients receive Qbrelis for free or at a nominal cost if enrolled in a trial.
---
3. Tips for Reducing Your Out‑of‑Pocket Cost
| Action | Why It Helps | How to Do It |
|--------|--------------|--------------|
| Ask about the “patient assistance program.” | Manufacturers often offer vouchers or discounts for qualifying patients. | Visit the Qbrelis or Bausch & Lomb website, or call 1‑800‑555‑1234. |
| Check your insurance’s “preferred pharmacy” list. | Some plans pay less at preferred locations. | Ask your pharmacist or look online. |
| Verify your copay under your current plan. | Some plans have lower copays for specialty drugs. | Review the plan’s “Benefit Summary” or contact member services. |
| Consider a Medicare Part B Advantage plan. | They sometimes cover specialty drugs at a lower cost. | Compare plans on Medicare.gov. |
| Look for clinical trial opportunities. | Trials can provide the drug free of charge. | Search clinicaltrials.gov for “brolucizumab” or ask your ophthalmologist. |
---
4. What to Discuss With Your Ophthalmologist
- Treatment frequency: Qbrelis typically requires 3–4 injections in the first 6 months, then as-needed.
- Alternatives: Other anti‑VEGF agents (e.g., aflibercept, bevacizumab) may be cheaper.
- Insurance coverage: Bring your plan info so the office can submit the appropriate prior authorization.
- Patient assistance: Ask if the office can help you enroll in a discount program.
---
5. International Perspective (Brief)
- United Kingdom (NHS): Qbrelis is generally not available; alternative anti‑VEGF drugs are used.
- Canada: Some provinces cover Qbrelis; costs are largely absorbed by public plans.
- Australia: Qbrelis is listed in the Pharmaceutical Benefits Scheme (PBS) at a subsidized rate, but the co‑pay is usually modest.
---
Bottom Line
- U.S. out‑of‑pocket cost: Typically $300–$800 per injection, with an annual cap of about $5,000–$8,000 for most commercial plans.
- Medicare patients: Copays range from $0–$75 per injection.
- Manufacturer discount/clinical trial: Potential to reduce or eliminate the cost for eligible patients.
Always confirm the exact figures with your healthcare provider and insurance plan, and don’t hesitate to ask for assistance programs if cost is a barrier. If you need help navigating these options, your eye care provider’s office or a pharmacist is a great first stop.